ALK delivers a research-driven global pharmaceutical company focusing on allergy treatment, prevention and diagnosis. ALK develops pharmaceutical products that target the actual cause of allergy.
Phone: +45 4574 7576
Boge Alle 6-8
Horsholm, 2970
Denmark
Date | Company | Round | Amount | Co-investors |
---|---|---|---|---|
2016-12-27 | Crystal Laboratory | Acquired | ||
2016-12-27 | Allergy Laboratories | Acquired | ||
2014-10-30 | SBT Aqua | Grant | $0.32M | Danish Eco-Innovation Program, Righospitalet, and Royal Unibrew |
2014-02-12 | Bio-Medical Services | Acquired | ||
2011-01-05 | DBV Technologies | Series C | $25.5M | Alto Invest, InnoBio, Lundbeckfond Ventures, Shire, and Sofinnova Partners |